VYNE Therapeutics Inc (VYNE)

[crudeoil24]

VYNE > Vyne Therapeutics Inc. is a specialty pharmaceutical company. The Company is focused on the developing proprietary therapies in dermatology. The Company's products include AMZEEQ minocycline, is used for the treatment of inflammatory lesions of moderate-to-severe acne vulgaris in adults and patients nine years of age and older, and ZILXI minocycline, is used for the treatment of inflammatory lesions of rosacea in adults. Its product pipeline includes FCD105, is a proprietary topical combination foam formulation of minocycline and adapalene for the treatment of moderate-to-severe acne vulgaris. In addition, it is also developing program for FMX114, which is a combination topical gel for the potential treatment of mild-to-moderate atopic dermatitis. The Company uses its proprietary Molecule Stabilizing Technology (MST) platform to develop FCD105.